Lotevail Eye Drop contains Loteprednol etabonate 0.5% w/v, a corticosteroid used for the treatment of ocular inflammation and pain associated with conditions such as allergic conjunctivitis, postoperative inflammation following ocular surgery, and anterior uveitis. Loteprednol etabonate exhibits potent anti-inflammatory activity by inhibiting the release of inflammatory mediators and reducing leukocyte infiltration, thereby alleviating symptoms such as redness, swelling, and discomfort. The formulation is designed for topical ophthalmic use, providing targeted delivery to the affected tissues with minimal systemic absorption. Lotevail Eye Drop should be used under the supervision of an ophthalmologist, with dosage and duration tailored to the severity of the condition. It is contraindicated in patients with viral, fungal, or mycobacterial ocular infections, and caution is advised in cases of glaucoma or known hypersensitivity to corticosteroids. Prolonged use may increase the risk of elevated intraocular pressure, cataract formation, or secondary infections; therefore, regular monitoring is recommended. Patients should avoid contact lens use during treatment unless otherwise directed. Lotevail Eye Drop offers an effective therapeutic option for managing ocular inflammation, improving patient comfort and visual outcomes when used appropriately.